A carregar...
Methylene blue treatment delays progression of perfusion-diffusion mismatch to infarct in permanent ischemic stroke
Stroke is a leading cause of morbidity and mortality in the world. Low-dose methylene blue (MB), which has been used safely to treat methemoglobinemia and cyanide poisoning in humans, has energy enhancing and antioxidant properties. We tested the hypothesis that methylene blue treatment delays progr...
Na minha lista:
| Publicado no: | Brain Res |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4907336/ https://ncbi.nlm.nih.gov/pubmed/25218555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brainres.2014.09.007 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|